A biotech and pharmaceutical venture fund co-established with CTBC and invested by the National Development Fund, with a total fund size of approximately NT$10 billion. The fund combines professional expertise and entrepreneurial experience to support startup growth in areas such as medical devices, biotech therapeutics, and nutritional supplements.
Hercules Bioventure Partners Taiwan CO., LTD.
NDF Collaborated Investor
Update:2026/11/10
Industries
Introduction
Country
Taiwan
Founded Year
2023
Unified Business No.
94085348
Total Paid-in
Capital
10,000,000 (NT$)
Investors Type
Venture Capital
Exclusive content for members
Members-only content. Please log in to access.
NDF Collaborated Investor
Yes